This inventor holds 1 USPTO granted patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Yuko Morikawa: Innovator in Cataract Treatment
Introduction
Yuko Morikawa is a prominent inventor based in Neyagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cataracts. Her innovative work has led to the development of valuable compounds that can improve patient outcomes.
Latest Patents
Yuko Morikawa holds a patent for 3-oxo-1,4-benzothiazine derivatives. This invention relates to compounds that are useful for the treatment of cataracts. The patent includes synthetic intermediates that are crucial for the production of these compounds.
Career Highlights
Morikawa is associated with Santen Pharmaceutical Co., Ltd., a company known for its focus on ophthalmic products. Her work at Santen has allowed her to explore and develop new therapeutic options for eye care.
Collaborations
Yuko has collaborated with notable colleagues such as Yoichi Kawashima and Atsutoshi Ota. These partnerships have enhanced her research and contributed to the advancement of her inventions.
Conclusion
Yuko Morikawa's contributions to cataract treatment through her innovative patents highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile